Posterior tibial nerve stimulation in patients with intractable interstitial cystitis

BJU International
Jimao Zhao, Jørgen Nordling

Abstract

To evaluate the efficacy of intermittent percutaneous posterior tibial nerve stimulation (PPTNS) in patients with refractory interstitial cystitis. One man and 13 women (mean age 58.3 years) with suprapubic or perineal pain were enrolled in a prospective open study, in which they had 10 weekly sessions of PPTNS. Their mean duration of symptoms was 8.3 years. All patients were previously diagnosed as having interstitial cystitis according to the National Institute of Diabetes and Digestive and Kidney Diseases criteria. The response to the treatment were assessed using voiding diary, visual analogue scale diary for a pain index, and the Interstitial Cystitis Problem Index (ICPI), O'Leary/Sant Interstitial Cystitis Symptom Index (ICSI) and the 36-item short-form health survey (SF-36) quality-of-life questionnaire. Of the 14 patients, 13 completed the 10 weeks of treatment with no complications; 12 continued treatment for a short period after the study. There were no statistically significant changes in pain scores, voiding frequency and volumes, or in the ICPI, ICSI and SF-36 scores. However, there was an improvement in some patients, with one having complete resolution of the pain. Intermittent PPTNS in patients with refractory i...Continue Reading

References

Mar 1, 1992·Trends in Neurosciences·R Dubner, M A Ruda
Feb 1, 1990·The Journal of Urology·P HannoA J Wein
Feb 1, 1980·The Journal of Urology·M FallB E Erlandson
Dec 1, 1996·British Journal of Urology·A C Thompson, T J Christmas
Mar 1, 1997·International Journal of Urology : Official Journal of the Japanese Urological Association·N Yoshimura, W C de Groat
Apr 29, 1998·The Journal of Urology·H S Shaker, M Hassouna
Jun 25, 1998·Behavioural Brain Research·W C de GroatJ R Roppolo
Mar 11, 1999·European Urology·I K WalshP F Keane
Oct 12, 2000·Urologia Internationalis·D H ZermannJ Schubert
Feb 15, 2001·The Journal of Urology·C F MaherP L Schluter
Dec 13, 2002·Neurourology and Urodynamics·Vera VandoninckBart L H Bemelmans
Feb 5, 2003·European Urology·Michael R van BalkenBart L H Bemelmans
Feb 1, 1949·The Journal of Urology·J R HAND

❮ Previous
Next ❯

Citations

Sep 12, 2012·Current Urology Reports·Christopher S Elliott, Christopher K Payne
Sep 19, 2012·Neuromodulation : Journal of the International Neuromodulation Society·Johanna M A E Biemans, Michael R van Balken
Dec 16, 2006·International Journal of Clinical Practice. Supplement·J Nordling
May 27, 2009·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·X GaméUNKNOWN Comité de Neuro-Urologie de l'Association Française d'Urologie
Aug 27, 2014·Obstetrics and Gynecology Clinics of North America·Susan Barr
Apr 25, 2007·Scandinavian Journal of Urology and Nephrology·Ahmet DanismanTibet Erdoğru
Mar 30, 2005·BJU International·Thomas LeippoldDaniel M Schmid
Apr 12, 2005·The Journal of Urology·Amrith Raj Rao, Omer M A Karim
Mar 15, 2006·Current Opinion in Anaesthesiology·Timothy J Ness
Jan 1, 2005·Current Opinion in Urology·Jørgen Nordling
Jul 4, 2008·Annales de réadaptation et de médecine physique : revue scientifique de la Société française de rééducation fonctionnelle de réadaptation et de médecine physique·M De SèzeG Amarenco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.